Conflicting results regarding the TS, p53, COX2, EGFR, MSH6 and MLH1 immune markers in CRC have been reported, and these can be explained by the different numbers of samples, the techniques used and the wide variation in methodologies used in the various studies. The gene discussed is EGFR; the disease is colorectal carcinoma.